{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:47:42Z","timestamp":1774612062770,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002770","name":"Cabinet Office, Government of Japan","doi-asserted-by":"publisher","award":["1065"],"award-info":[{"award-number":["1065"]}],"id":[{"id":"10.13039\/501100002770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cbi.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:04:54Z","timestamp":1537473894000},"page":"185-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (TAK-875)-induced acute liver injury in mice"],"prefix":"10.1016","volume":"296","author":[{"given":"Yuya","family":"Urano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-601X","authenticated-orcid":false,"given":"Shingo","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2018.09.011_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2018.09.011_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.109.162651","article-title":"Intrinsic versus idiosyncratic drug-induced hepatotoxicity - two villains or one?","volume":"332","author":"Roth","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.09.011_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/dom.12467","article-title":"Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial","volume":"17","author":"Kaku","year":"2015","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.cbi.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/dom.12693","article-title":"Long-term safety and efficacy of fasiglifam (TAK-875), a GPR40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study","volume":"18","author":"Kaku","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.cbi.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1124\/dmd.115.064121","article-title":"Fasiglifam (TAK-875) inhibits hepatobiliary transporters: a possible factor contributing to fasiglifam-induced liver injury","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2018.09.011_bib8","first-page":"50","article-title":"Fasiglifam (TAK-875) alters bile acid homeostasis in rats and dogs: a potential cause of drug induced liver injury","volume":"157","author":"Wolenski","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2018.09.011_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/toxsci\/kfs223","article-title":"A\u00a0decade of toxicogenomic research and its contribution to toxicological science","volume":"130","author":"Chen","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/nar\/gku955","article-title":"A\u00a0large-scale toxicogenomics database","volume":"43","author":"Igarashi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2018.09.011_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jbiotec.2005.03.022","article-title":"Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action","volume":"119","author":"Ganter","year":"2005","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.cbi.2018.09.011_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrfmmm.2003.11.015","article-title":"Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in\u00a0vivo and human hepatocytes in\u00a0vitro","volume":"549","author":"Kier","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2018.09.011_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/jpet.105.096347","article-title":"Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils","volume":"316","author":"Waring","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.09.011_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tox.2014.07.005","article-title":"Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats","volume":"324","author":"Hanafusa","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2018.09.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-4-26","article-title":"Statistical implications of pooling RNA samples for microarray experiments","volume":"4","author":"Peng","year":"2003","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.cbi.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/biot.201000046","article-title":"Hepatic transcription response to high-fat treatment in mice: microarray comparison of individual vs. pooled RNA samples","volume":"5","author":"Do","year":"2010","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.cbi.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1073\/pnas.1304046110","article-title":"Eosinophils secrete IL-4 to facilitate liver regeneration","volume":"110","author":"Goh","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2018.09.011_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hep.28112","article-title":"Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis","volume":"63","author":"Fujita","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/bib\/bbr002","article-title":"The what, where, how and why of gene ontology - a primer for bioinformaticians","volume":"12","author":"du Plessis","year":"2011","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.cbi.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.cbi.2018.09.011_bib21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2018.09.011_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biocel.2015.01.015","article-title":"The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis","volume":"61","author":"Kolb","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2018.09.011_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.06.003","article-title":"Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice","volume":"87","author":"Shimizu","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2018.09.011_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1872-034X.2011.00852.x","article-title":"Dexamethasone attenuates lipopolysaccharide-induced liver injury by downregulating glucocorticoid-induced tumor necrosis factor receptor ligand in Kupffer cells","volume":"41","author":"Wei","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cbi.2018.09.011_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tiv.2018.01.019","article-title":"Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injury","volume":"48","author":"Xu","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2018.09.011_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.248","article-title":"ER stress induces NLRP3 inflammasome activation and hepatocyte death","volume":"6","author":"Lebeaupin","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2018.09.011_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2015.11.016","article-title":"Experimental models of hepatotoxicity related to acute liver failure","volume":"290","author":"Maes","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.09.011_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/ijms18051018","article-title":"Drug-induced liver injury: cascade of events leading to cell death, apoptosis or necrosis","volume":"18","author":"Iorga","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2018.09.011_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17425255.2017.1246534","article-title":"Drug-induced steatohepatitis","volume":"13","author":"Dash","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2018.09.011_bib30","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2018.09.011_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"Malhi","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cbi.2018.09.011_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/toxsci\/kfx143","article-title":"Hepatic amiodarone lipotoxicity is ameliorated by genetic and pharmacological inhibition of endoplasmatic reticulum stress","volume":"159","author":"Erez","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2018.09.011_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.102.039404","article-title":"Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia","volume":"303","author":"Hartmann","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.09.011_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/clpt.2012.43","article-title":"A\u00a0multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes","volume":"92","author":"Leifke","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2018.09.011_bib35","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/hep.25801","article-title":"Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure","volume":"56","author":"Marques","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2018.09.011_bib36","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3748\/wjg.v23.i17.3043","article-title":"Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury","volume":"23","author":"Qin","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2018.09.011_bib37","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/TP.0000000000001411","article-title":"Innate immune regulations and liver ischemia-reperfusion injury","volume":"100","author":"Lu","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cbi.2018.09.011_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cbi.2018.09.011_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/er.2011-1042","article-title":"The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases","volume":"33","author":"Prudente","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2018.09.011_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-cellbio-100913-013226","article-title":"Regulated cell death: signaling and mechanisms","volume":"30","author":"Ashkenazi","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2018.09.011_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kft232","article-title":"Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury","volume":"137","author":"Laifenfeld","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2018.09.011_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.devcel.2008.10.015","article-title":"UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators","volume":"15","author":"Rutkowski","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cbi.2018.09.011_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hep.25611","article-title":"Cidea promotes hepatic steatosis by sensing dietary fatty acids","volume":"56","author":"Zhou","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2018.09.011_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncpgasthep0602","article-title":"Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis","volume":"3","author":"Geier","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2018.09.011_bib45","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/00498250802040584","article-title":"Bile acid transporters in health and disease","volume":"38","author":"Kosters","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2018.09.011_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2015.03.022","article-title":"Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice","volume":"286","author":"Harris","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.09.011_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/ml1000855","article-title":"Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist","volume":"1","author":"Negoro","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2018.09.011_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027270","article-title":"AMG 837: a novel GPR40\/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents","volume":"6","author":"Lin","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2018.09.011_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/ml4000673","article-title":"Discovery of TUG-770: a highly potent free fatty acid receptor 1 (FFA1\/GPR40) agonist for treatment of type 2 diabetes","volume":"4","author":"Christiansen","year":"2013","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718308196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718308196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:46:45Z","timestamp":1762112805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718308196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"alternative-id":["S0009279718308196"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.09.011","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (TAK-875)-induced acute liver injury in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}